Results for tag: "Amino Acid Metabolism Disorder Drugs"

The Amino Acid Metabolism Disorder Drugs market is a subset of the larger Drug Discovery market. It focuses on the development of drugs to treat disorders related to the metabolism of amino acids. These disorders can be caused by genetic mutations, environmental factors, or a combination of both. The drugs developed in this market are designed to correct the underlying metabolic disorder, allowing patients to lead healthier lives. The market is driven by the increasing prevalence of genetic disorders, as well as the need for more effective treatments. Additionally, advances in technology have enabled the development of more targeted drugs, which can be tailored to the specific needs of each patient. Companies in the Amino Acid Metabolism Disorder Drugs market include AbbVie, Amicus Therapeutics, BioMarin Pharmaceuticals, and Shire. Show Less Read more